The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein Kinase
Data up to Jan 2025
Total Citations Per Year
Abstract
References (30)
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
2003 • 7,305 citations
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
2002 • 4,335 citations
Obesity and insulin resistance
2000 • 3,076 citations
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
2005 • 2,774 citations
Metformin and reduced risk of cancer in diabetic patients
2005 • 2,278 citations
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
2005 • 1,901 citations
The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress
2004 • 1,710 citations
Adipogenesis and Obesity: Rounding Out the Big Picture
1996 • 1,268 citations
Metformin Is an AMP Kinase–Dependent Growth Inhibitor for Breast Cancer Cells
2006 • 1,038 citations
Adiponectin: More Than Just Another Fat Cell Hormone?
2003 • 1,004 citations
Minireview: The AMP-Activated Protein Kinase Cascade: The Key Sensor of Cellular Energy Status
2003 • 989 citations
Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl–CoA carboxylase inhibition and AMP-activated protein kinase activation
2002 • 969 citations
Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin
2006 • 910 citations
Metformin Inhibits Mammalian Target of Rapamycin–Dependent Translation Initiation in Breast Cancer Cells
2007 • 903 citations
Systemic Treatment with the Antidiabetic Drug Metformin Selectively Impairs p53-Deficient Tumor Cell Growth
2007 • 894 citations
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome
2006 • 863 citations
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
2008 • 835 citations
AMP-activated Protein Kinase Suppresses Protein Synthesis in Rat Skeletal Muscle through Down-regulated Mammalian Target of Rapamycin (mTOR) Signaling
2002 • 829 citations
mTOR, translation initiation and cancer
2006 • 592 citations
AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the α2 isoform
1998 • 431 citations
The blooming of the French lilac
2001 • 355 citations
Metabolic Syndrome in Normal-Weight Americans
2004 • 309 citations
The Role of Insulin Receptor Isoforms and Hybrid Insulin/IGF-I Receptors in Human Cancer
2007 • 248 citations
The Underlying Basis for Obesity: Relationship to Cancer
2002 • 226 citations
Hormone responsive human breast cancer in long-term tissue culture: effect of insulin.
1976 • 222 citations
Association of Diet-Induced Hyperinsulinemia With Accelerated Growth of Prostate Cancer (LNCaP) Xenografts
2007 • 176 citations
Serum Adiponectin Concentrations and Tissue Expression of Adiponectin Receptors Are Reduced in Patients with Prostate Cancer: A Case Control Study
2007 • 175 citations
Adiponectin signals in prostate cancer cells through Akt to activate the mammalian target of rapamycin pathway
2007 • 67 citations
Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome?
2006 • 59 citations
The effects of metformin on pathologic complete response (pCR) rates in diabetic breast cancer (BC) patients receiving neoadjuvant systemic therapy (NST)
2008 • 12 citations
Cited By (0)
No citing papers found in database